aap Implantate AG completes capital increase

aap Implantate AG, a German medical technology company specialized in healing bone fractures, joint replacement, bone cements and biomaterials segments, has successfully completed a capital increase with subscription rights. The capital increase was placed in full by an issue of 1,460,857 registered shares. The shares that were not taken up as rights were strongly oversubscribed.

Subject to the recording of the capital increase in the companies’ register of Charlottenburg district court, Berlin, the company’s capital stock will increase by EUR 1,460,857 from the present EUR 15,058,300 to EUR 16,519,157, divided into the same number of registered shares. The new shares are likely to be included in the existing Frankfurt stock exchange listing from the beginning of October 2005. From the capital increase the company receives EUR 2.3 million before transaction costs. The proceeds are intended to be used for financing an acquisition in the biomaterials segment and to continue to step up its operative business.